Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1505 studies found for:    Lipid Storage Diseases

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
Lipid Storage Diseases (1505 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)
Condition: Neutral Lipid Storage Disease
Intervention: Drug: Fibrate treatment
2 Unknown † Genetic Origin of Lipid Disorders
Condition: Lipid Disorder
Intervention:
3 Recruiting Genes Involved in Lipid Disorders
Condition: Dyslipidemia
Intervention:
4 Recruiting Biomarker for Gaucher Disease
Conditions: Lysosomal Storage Diseases;   Gaucher Disease;   Sphingolipidoses
Intervention:
5 Recruiting Natural History Study of Children With Metachromatic Leukodystrophy
Conditions: Leukodystrophy, Metachromatic;   Hereditary Central Nervous System Demyelinating Diseases;   Brain Diseases, Metabolic, Inborn;   Brain Diseases, Metabolic;   Brain Diseases;   Central Nervous System Diseases;   Nervous System Diseases;   Sulfatidosis;   Sphingolipidoses;   Lysosomal Storage Diseases, Nervous System;   Leukoencephalopathies;   Demyelinating Diseases;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Lipidoses;   Lipid Metabolism, Inborn Errors;   Lysosomal Storage Diseases;   Metabolic Diseases;   Lipid Metabolism Disorders
Intervention: Other: Natural History Study of Children With Metachromatic Leukodystrophy
6 Completed
Has Results 		Lipid Management in Clinical Practice (MK-0524A-115)
Condition: Lipid Metabolism Disorder
Intervention:
7 Active, not recruiting Physical Activity and Nutrition in Children Study
Conditions: Overweight;   Glucose Metabolism Disorders;   Lipid Metabolism Disorders;   Blood Pressure;   Fitness
Intervention: Behavioral: lifestyle counseling
8 Recruiting MT2013-31:Allo BMT for Metabolic Disorders, Osteopetrosis and Males With Rett Syndrome
Conditions: Mucopolysaccharidosis I;   Mucopolysaccharidosis II;   Mucopolysaccharidosis VI;   Mucopolysaccharidosis VII;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Glycoprotein Metabolic Disorders;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Adrenoleukodystrophy;   Peroxisomal Disorders;   Osteopetrosis;   Rett Syndrome;   Sphingolipidosis;   Gangliosidosis;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann Pick B;   Niemann Pick C Subtype 2;   I-cell Disease
Interventions: Procedure: blood stem cell transplant;   Drug: Rabbit Anti-Thymocyte Globulin (ATG);   Drug: Fludarabine;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Cyclosporine A (CSA);   Drug: Methylprednisolone;   Drug: Mycophenolate Mofetil (MMF);   Drug: Granulocyte-Colony Stimulating Factor (G-CSF);   Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF);   Drug: N-acetylcysteine;   Drug: Celecoxib;   Drug: Vitamin E;   Drug: Alpha Lipoic Acid
9 Terminated
Has Results 		Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Conditions: Hurler's Syndrome;   Maroteaux-Lamy Syndrome;   Sly Syndrome;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Sphingolipidoses;   Krabbe Disease;   Wolman's Disease;   Niemann-Pick Disease Type B;   Niemann-Pick Disease, Type C
Interventions: Procedure: Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Campath-1H;   Drug: Busulfan
10 Completed Pharmacological Regulation of Fat Transport in Metabolic Syndrome
Conditions: Obesity;   Lipid Disorders;   Hypertriglyceridemia;   Cardiovascular Disease
Intervention: Drug: Atorvastatin and fenofibrate
11 Active, not recruiting Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)
Conditions: Obesity;   Disorder of Lipid Storage and Metabolism;   Lipid Metabolism Disorders;   Metabolic Disorder
Intervention: Behavioral: Exercise
12 Active, not recruiting Effect of Age on Glucose and Lipid Metabolism
Conditions: Glucose Metabolism Disorders;   Lipid Metabolism Disorders;   Metabolic Diseases
Intervention: Behavioral: Aerobic Exercise
13 Completed
Has Results 		Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Condition: Lipid Metabolism Disorders
Intervention: Drug: Fluvastatin sodium
14 Completed Omega 3 in Intervention Spinal Cord Injured People
Conditions: Lipid Metabolism Disorders;   Peroxidase; Defect
Interventions: Dietary Supplement: w3 supplement in SCI;   Other: placebo
15 Completed Stearidonic Acid and Lipid Metabolism
Condition: Lipid Metabolism Disorders
Interventions: Dietary Supplement: Echium oil (SDA-rich oil);   Dietary Supplement: high-oleic acid sunflower oil (HOSO) (low in SDA)
16 Active, not recruiting Study of the Long-term Effects of Exercise on Heath Indicators in Older People
Conditions: Hypertension With Complications and Secondary Hypertension;   Overweight and Obesity;   Lipid Metabolism Disorders;   Sarcopenia;   Osteoporosis;   Personal Satisfaction
Intervention: Behavioral: Exercise training
17 Completed Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis
Conditions: Lipid Metabolism Disorders;   Sterols;   Diet, High-Fat;   Cholesterol;   Fatty Acids;   Hyperlipidemias
Interventions: Behavioral: Changes in cholesterol metabolism;   Other: Lean red meat diet;   Other: Fat red meat diet
18 Unknown † A Mediterranean-style Breakfast and Postprandial Lipid Disorders in Obese Pre-adolescents and Adults
Condition: Obesity
Interventions: Dietary Supplement: Mediterranean-style breakfast;   Dietary Supplement: Western-style breakfast
19 Completed Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia
Condition: Lipid Metabolism Disorder
Intervention: Drug: ezetimibe
20 Completed
Has Results 		Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Intervention: Drug: mipomersen sodium
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years